oceansbio
A human implantable medical device company based on AI technology.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | Seed | |
| Total Funding | 000k | ||
Related Content
OceansBio is a pioneering biotechnology company based in Seoul, South Korea, specializing in the development of advanced healthcare and environmental solutions. The company focuses on creating innovative products that address critical needs in both the medical and ecological sectors. OceansBio serves a diverse range of clients, including hospitals, research institutions, and environmental agencies, primarily within the Asian market but with a growing global presence.
The business operates on a B2B (business-to-business) model, partnering with other organizations to integrate its biotechnological advancements into their operations. Revenue is generated through the sale of proprietary products, licensing agreements, and collaborative research projects. OceansBio's core offerings include cutting-edge diagnostic tools, therapeutic solutions, and eco-friendly technologies aimed at reducing environmental impact.
The company's commitment to research and development is evident through its state-of-the-art R&D center, which drives continuous innovation and ensures the highest standards of quality and efficacy in its products. By leveraging its expertise in biotechnology, OceansBio aims to contribute significantly to the improvement of public health and the preservation of the environment.
Keywords: biotechnology, healthcare, environmental sustainability, diagnostic tools, therapeutic solutions, eco-friendly technologies, research and development, B2B model, innovation, South Korea.